Literature DB >> 23527710

TNF-alpha, IL-4R-alpha and IL-4 polymorphisms in mild to severe asthma from Italian Caucasians.

F L M Ricciardolo1, V Sorbello, M Silvestri, M Giacomelli, V M G Debenedetti, M Malerba, G Ciprandi, G A Rossi, A Rossi, M Bontempelli.   

Abstract

Asthma is a chronic airway inflammatory disease associated with airway hyperresponsiveness which affects subjects with genetic predisposition. An association has been reported between some polymorphisms in various cytokine genes and asthma. Most of them are single nucleotide polymorphisms (SNPs). These polymorphisms are detected in the protein coding sequence or in the promoter region thus influencing cytokine production. We investigated the involvement of SNP mapping in 5 cytokine genes in mild to severe asthmatics of Italian Caucasians. The frequency of alleles and genotypes, relatively to 10 allelic specificities of the cytokine genes, was defined in 57 asthmatics and in 124 control subjects by a Polymerase Chain Reaction-Sequence Specific Primer method. TNF-alpha -308A and TNF-alpha -238A allele frequencies were higher in asthmatics than in controls (p less than 0.001). Significant differences in the frequency of IL-4 -590T allele and of IL-4Ralpha +1902A allele were also detected in asthmatics in comparison with controls (pless than 0.001 and p=0.005, respectively). Similarly, IL-1alpha -889C allele was present in 84.1 percent of asthmatics and in 70.2 percent of controls (p=0.013). Furthermore, the IL-4Ralpha +1902A/A and IL-1alpha -889C/C homozygous conditions and the TNF-alpha -308G/A, TNF-alpha -238G/A, IL-4 -590T/C and IL-10 -1082G/A heterozygous conditions were significantly associated with asthma (p less than 0.05). ACA haplotype of IL-10 was observed only in asthmatic patients. This study reports, for the first time, the frequency of 10 different single nucleotide polymorphisms in 5 cytokine genes in the Italian Caucasians. Furthermore, we also indicate that in our population some single nucleotide polymorphisms are associated with mild to severe bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23527710     DOI: 10.1177/039463201302600107

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  6 in total

1.  Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Michael L Kashon; Victor J Johnson; Zana L Lummus; Kara Fluharty; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Immunotoxicol       Date:  2015-09-04       Impact factor: 3.000

Review 2.  Topical Review: The Emerging Field of Epigenetics: Informing Models of Pediatric Trauma and Physical Health.

Authors:  Nicole R Nugent; Amy Goldberg; Monica Uddin
Journal:  J Pediatr Psychol       Date:  2015-03-29

Review 3.  Children's Inter-Individual Variability and Asthma Development.

Authors:  Rami Saadeh; James Klaunig
Journal:  Int J Health Sci (Qassim)       Date:  2015-10

4.  Single Nucleotide and Copy-Number Variants in IL4 and IL13 Are Not Associated with Asthma Susceptibility or Inflammatory Markers: A Case-Control Study in a Mexican-Mestizo Population.

Authors:  Enrique Ambrocio-Ortiz; Gustavo Galicia-Negrete; Gloria Pérez-Rubio; Areli J Escobar-Morales; Edgar Abarca-Rojano; Alma D Del Angel-Pablo; Manuel D J Castillejos-López; Ramcés Falfán-Valencia
Journal:  Diagnostics (Basel)       Date:  2020-04-30

Review 5.  Genetic basis of asthma.

Authors:  Surinder K Jindal
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

6.  Interleukin 4 gene polymorphism (-589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies.

Authors:  Ahmad Kousha; Armita Mahdavi Gorabi; Mehdi Forouzesh; Mojgan Hosseini; Markov Alexander; Danyal Imani; Bahman Razi; Mohammad Javad Mousavi; Saeed Aslani; Haleh Mikaeili
Journal:  BMC Immunol       Date:  2020-10-21       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.